
(MedPage Today) — SAN FRANCISCO — Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF; Biktarvy) or continuing a previous antiretroviral therapy (ART) in maintaining…
Source link : https://www.medpagetoday.com/meetingcoverage/croi/114716
Author :
Publish date : 2025-03-18 18:57:00
Copyright for syndicated content belongs to the linked
Source.